- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/05 - CorynebacteriumPropionibacterium
Patent holdings for IPC class A61K 39/05
Total number of patents in this class: 260
10-year publication summary
|
16
|
22
|
18
|
19
|
26
|
15
|
8
|
20
|
8
|
12
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1599 |
15 |
| Eligo Bioscience | 95 |
8 |
| The Regents of the University of California | 20868 |
7 |
| AC Immune S.A. | 271 |
5 |
| Sanofi Pasteur Inc. | 219 |
5 |
| Serum Institute of India Private Limited | 107 |
5 |
| Zoetis Services LLC | 1539 |
5 |
| Novartis AG | 10174 |
4 |
| Nestec S.A. | 2540 |
4 |
| Duke University | 3182 |
4 |
| Cansino Biologics Inc. | 87 |
4 |
| KM Biologics Co., Ltd | 93 |
4 |
| Biogen MA Inc. | 942 |
3 |
| Cedars-Sinai Medical Center | 1209 |
3 |
| Cornell University | 3450 |
3 |
| Fina BioSolutions, LLC | 21 |
3 |
| Intervet International B.V. | 1338 |
3 |
| Moredun Research Institute | 29 |
3 |
| Qu Biologics Inc. | 25 |
3 |
| Sanofi Pasteur SA | 56 |
3 |
| Other owners | 166 |